2021 Sterile Drug Market Report & CDMO Pricing Study

2021 Sterile Drug Market Report & CDMO Pricing Study

Order now and learn more about:

  • 2021 pricing benchmarks, based on actual quotes by providers
  • Detailed pricing from competitors across NA, EU, and Asia
  • A comprehensive landscape of top 25 Sterile CDMOs
  • Input from subject matter experts (SMEs)
  • Projections on ongoing growth of the sterile drugs market
  • Analysis of new technologies in development and automation

2021 Sterile Report Brings Value to Innovators, CDMOs, & PE Investors

Invaluable Pricing and Market Data for Innovators, CDMOs, or PE Investors

Nice Insight is in the process of compiling primary and secondary data to create a comprehensive report on the dynamic market for sterile injectable drugs, including development, manufacturing, packaging, and commercialization. The report will explore innovations in delivery systems, manufacturing equipment and processes, and automation for sterile injectable drugs, including established products and next-generation and personalized medicines. The report will include a proprietary pricing study providing pricing data for a full range of line items associated with sterile drug manufacturing and packaging.

What You Get With the Report

  • Current 2021 pricing benchmarks based on actual quotes given by providers for all typical service line items within sterile drug manufacturing projects.
  • Ability to measure whether your pricing levels are right against high, low and median pricing in the marketplace.
  • A comprehensive view of the competitive landscape with a directory of the Top 25+ sterile drug CDMOs across major regions today, including capabilities, capacity, proprietary technologies, and locations.
  • Input from subject matter experts (SMEs) from CDMOs and buyers of outsourced services.
  • Projections on ongoing growth of the sterile drugs market.
  • Analysis of new technologies in development and automation.

For more information:

Order your
2021 Sterile Drug Market Report
  • An Account Manager will reach out to qualify your information.
  • Company emails only - personal emails are not accepted.

Over 600 Additional Hours of Data Collection & Analysis

  • Study Started: April 2021
  • Data Collection: May 2020 - August 2021
  • Collation & Analysis: August 2021 - October 2021
  • Report Available: October 2021
  • Page Count: 150+
  • CDMOs Covered: 25+